Cytosar 1000 mg Injection
  1. Home
  2. Pharma Products
  3. Pfizer Ltd
  4. Cytosar 1000 mg Injection

Cytosar 1000 mg Injection

Cytosar 1000 mg Injection contains cytarabine, an antineoplastic medicine used in the treatment of certain blood cancers. It interferes with DNA synthesis and helps inhibit the growth of rapidly dividing cancer cells. The injection is administered by a qualified healthcare professional according to the prescribed chemotherapy protocol.

BUY NOW

Category

Cytosar 1000 mg Injection contains cytarabine and is used primarily in chemotherapy regimens for acute leukemias. Cytarabine acts mainly during the DNA synthesis phase of the cell cycle by inhibiting DNA polymerase activity. Pfizer documentation lists a 1000 mg/50 mL cytarabine presentation at a concentration of 20 mg/mL for pharmacy bulk use. The dose, route, dilution, and treatment schedule depend on the specific chemotherapy regimen and must be determined by the treating specialist.

Technical Specification

Specification Details
Active Ingredient Cytarabine 1000 mg
Concentration 20 mg/mL
Total Volume 50 mL
Dosage Form Sterile Solution for Injection
Therapeutic Class Antimetabolite
Storage 20°C to 25°C

Product Also Known As

Cytosar 1000 mg Injection, Cytosar 1 g Injection, Cytarabine 1000 mg Injection, Cytarabine 1 g Injection, Cytarabine Oncology Injection, Ara-C 1000 mg Injection